Combined Focused Next-Generation Sequencing Assays to Guide Precision Oncology in Solid Tumors: A Retrospective Analysis from an Institutional Molecular Tumor Board.

Cancers (Basel) · 2022 · PMC9496918 · PMID 36139590

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

did not reach statistical significancep = 0.052so close (0.05 < p ≤ 0.1)

Despite the numerical difference, this did not reach statistical significance (Mann–Whitney U test, p = 0.052 and p = 0.083, respectively, for the all-patients population and for patients receiving off-label treatments).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.